J. Cornel

D. Rizopoulos, E. Boersma, J. Cornel, 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Relation between pharmacological stress ECG, 13NH3-PET/CT outcome and the occurrence of cardiac events during follow-up in women with chest pain

J. Cornel, V. Umans, F. M. van der Zant, 2020, Nuclear medicine communications.

Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.

D. Prabhakaran, P. Armstrong, H. White, 2015, American heart journal.

Long-term outcomes for women vs. men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TRILOGY ACS trial

D. Prabhakaran, H. White, D. Cyr, 2015 .

Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study

E. Boersma, J. Cornel, I. Kardys, 2019, Thrombosis and Haemostasis.

Improved detection of viable myocardium with fluorodeoxyglucose-labeled single-photon emission computed tomography in a patient with hibernating myocardium: Comparison with rest-redistribution thallium 201-labeled single-photon emission computed tomography

Jeroen J. Bax, C. Visser, J. Cornel, 1997, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Hemodynamic changes, plasma catecholamine responses, and echocardiographically detected contractile reserve during two different dobutamine-infusion protocols.

A. Salustri, J. Roelandt, J. Cornel, 1997, Journal of cardiovascular pharmacology.

Quantitative angiographic measurements of isolated left anterior descending coronary artery stenosis. Correlation with exercise echocardiography and technetium-99m 2-methoxy isobutyl isonitrile single-photon emission computed tomography.

A. Salustri, J. Roelandt, P. D. de Feyter, 1995, Journal of the American College of Cardiology.

Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.

J. Kasprzak, R. Becker, R. Mehran, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial.

J. Kasprzak, R. Becker, R. Mehran, 2013, The Journal of invasive cardiology.

Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

C. Held, C. Cannon, A. Budaj, 2017, American heart journal.

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

C. Held, P. Armstrong, F. Van de Werf, 2015, The American journal of cardiology.

Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T.

J. Tijssen, R. D. de Winter, C. Visser, 2003, Journal of the American College of Cardiology.

A multidisciplinary care pathway for the evaluation of falls and syncope in geriatric patients

J. Cornel, R. Vogels, R. Jansen, 2015 .

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.

J. Tijssen, J. Eikelboom, J. Cornel, 2019, American heart journal.

Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA.

J. Reiber, A. Salustri, J. Roelandt, 1992, European heart journal.

Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial

C. Cannon, S. Stevens, L. Wallentin, 2011, BMJ : British Medical Journal.

N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk.

R. D. de Winter, J. Cornel, J. V. van Straalen, 2011, The American journal of medicine.

Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study

J. Tijssen, R. J. Winter, J. Cornel, 2007, The Lancet.

Heart failure programmes in countries with a primary care‐based health care system. Are additional trials necessary? Design of the DEAL‐HF study

D. J. Veldhuisen, A. Hoes, J. Cornel, 2005, European journal of heart failure.

Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial

D. Prabhakaran, P. Armstrong, H. White, 2016, European heart journal. Acute cardiovascular care.

Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.

D. Rizopoulos, E. Boersma, J. Cornel, 2017, Kidney international.

Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS

R. Holman, E. Peterson, S. Stevens, 2017, Diabetes, obesity & metabolism.

The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction.

J. Cornel, V. Umans, T. van der Ploeg, 2007, International journal of cardiology.

Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial.

S. Stevens, L. Wallentin, V. Fridrich, 2015, American heart journal.

Inhibition and Patient Outcomes (PLATO) Trial In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet ST-Elevation Acute Coronary Syndrome Patients Managed With or Without − Non Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in

C. Held, C. Cannon, K. Mahaffey, 2014 .

Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial

C. Held, C. Cannon, K. Mahaffey, 2014, Circulation.

Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress?

J. Roelandt, J. Cornel, R. V. van Domburg, 1996, Journal of the American College of Cardiology.

ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.

J. Tijssen, R. D. de Winter, J. Cornel, 2007, Journal of electrocardiology.

ment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study

Freek, R. J. Winter, J. Cornel, 2007 .

UvA-DARE ( Digital Academic Repository ) Early invasive versus selectively invasive management for acute coronary syndromes

J. Tijssen, R. J. Winter, J. Cornel, 2005 .

N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.

J. Tijssen, R. D. de Winter, J. Cornel, 2007, American heart journal.

Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.

J. Tijssen, R. D. de Winter, J. Cornel, 2008, European heart journal.

Early invasive versus selectively invasive management for acute coronary syndromes.

J. Tijssen, R. D. de Winter, J. Cornel, 2005, The New England journal of medicine.

Dobutamine-atropine stress echocardiography in elderly patients unable to perform an exercise test. Hemodynamic characteristics, safety, and prognostic value.

I. R. Thomson, J. Roelandt, F. T. ten Cate, 1994, Archives of internal medicine.

Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.

C. Held, B. Lewis, C. Cannon, 2014, American heart journal.

Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial

E. Boersma, J. Cornel, R. Oemrawsingh, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon?

J. Roelandt, J. Cornel, P. Fioretti, 1994, The American journal of cardiology.

Correlation of coronary stenosis by quantitative coronary arteriography with exercise echocardiography.

A. Salustri, J. Roelandt, F. T. ten Cate, 1995, The American journal of cardiology.

Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization.

Jeroen J. Bax, J. Roelandt, J. Cornel, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy.

H. Crijns, J. Cornel, R. D. de Jong, 2001, European journal of heart failure.

Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study.

J. Roelandt, J. Kasprzak, J. Cornel, 2000, European heart journal.

Agreement and disagreement between “metabolic viability” and “contractile reserve” in akinetic myocardium

Jeroen J. Bax, J. Cornel, E. Boersma, 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.

Jeroen J. Bax, C. Visser, J. Cornel, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction.

Jeroen J. Bax, J. Roelandt, J. Cornel, 1997, Heart.

Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.

D. Prabhakaran, P. Armstrong, H. White, 2017, Clinical chemistry.

Colchicine in Patients with Chronic Coronary Disease.

G. Hankey, J. Tijssen, J. Eikelboom, 2020, The New England journal of medicine.

Safety and efficacy of treatment with platelet GPIIb/IIIa receptor blockade in unstable angina patients awaiting PTCA at a referring clinic.

J. Bronzwaer, J. Cornel, V. Umans, 1999, International journal of cardiovascular interventions.

Colchicine in Stable Coronary Artery Disease.

J. Cornel, A. Mosterd, S. Nidorf, 2019, Clinical therapeutics.

Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial.

C. Held, B. Lewis, S. Stevens, 2013, American heart journal.

Characteristics and prognostic value of right ventricular (dys)function in patients with non‐ischaemic dilated cardiomyopathy assessed with cardiac magnetic resonance imaging

A. van Rossum, J. Cornel, P. M. van de Ven, 2021, ESC heart failure.

Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability

Jeroen J. Bax, E. E. van der Wall, J. Cornel, 1997, The International Journal of Cardiac Imaging.

P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes.

E. Ohman, F. Rockhold, T. Povsic, 2019, JAMA cardiology.

Prediction of improvement of ventricular function after revascularization. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography.

Jeroen J. Bax, J. Roelandt, J. Cornel, 1997, European heart journal.

Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography.

A. Salustri, J. Roelandt, F. T. ten Cate, 1994, The American journal of cardiology.

Patient work in end-stage heart failure: a prospective longitudinal multiple case study

G. van der Wal, J. Cornel, D. Willems, 2006, Palliative medicine.

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.

D. Prabhakaran, P. Armstrong, H. White, 2012, JAMA.

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

P. Libby, P. Pais, J. Varigos, 2017, The Lancet.

Predictive accuracy of echocardiographic response of mildly dyssynergic myocardial segments to low-dose dobutamine.

Jeroen J. Bax, J. Cornel, J. Vanoverschelde, 1997, The American journal of cardiology.

Myocardial β-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388

A. van Waarde, W. Vaalburg, J. Cornel, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Assessment of myocardial viability before revascularization: Can sestamibi accurately predict functional recovery?

J. Cornel, P. Fioretti, A. Reijs, 1996 .

Percutaneous coronary intervention with off-site cardiac surgery backup for acute myocardial infarction as a strategy to reduce door-to-balloon time.

J. Cornel, T. Wharton, V. Umans, 2007, The American journal of cardiology.

Dobu & mine-Atcopine Stress Sestamibi Scintigraphy in Women With Chest Pain

Marcel, J. Cornel, M. E., 2004 .

Dobutamine stress-redisstribution-reinjection versus rest-redistribution thallium-201 spect in the assessment of myocardial viability

Jeroen J. Bax, J. Cornel, A. Elhendy, 1997, The International Journal of Cardiac Imaging.

Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain.

J. Cornel, R. V. van Domburg, A. Elhendy, 1996, The American journal of cardiology.

Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes

K. Mahaffey, R. Becker, M. Valgimigli, 2014, Thrombosis and Haemostasis.

Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.

E. Boersma, J. Cornel, R. Oemrawsingh, 2013, JAMA internal medicine.

Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols

Jeroen J. Bax, C. Visser, R. Heine, 2005, European Journal of Nuclear Medicine.

Assessment of myocardial viability by FDG imaging with SPECT

Jeroen J. Bax, C. Visser, E. Wall, 1998 .

Long-term Clinical Outcome and MIBI SPECT Parameters in Percutaneous Coronary Interventions

J. Cornel, V. Umans, F. M. van der Zant, 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis

J. Cornel, F. Visseren, K. Wever, 2021, PloS one.

Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.

Deepak L. Bhatt, A. Parkhomenko, M. Sabatine, 2018, Journal of the American College of Cardiology.

PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers.

J. Cornel, E. Stroes, H. Verberne, 2019, JACC. Cardiovascular imaging.

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

M. Keltai, B. Lewis, A. Budaj, 2019, Journal of the American Heart Association.

Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial.

D. Prabhakaran, P. Armstrong, H. White, 2014, American heart journal.

Early invasive vs. selectively invasive management for acute coronoary syndromes

R. J. Winter, J. Cornel, F. Windhausen, 2006 .

n g l a d r n a l of m e d i c i n e Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. Libby, P. Pais, R. Glynn, 2017 .

266 Deventer-Alkmaar heart failure project (DEAL-HF). Prevention of (re_hospitalisation for heart failure by a nurse and physician-directed, multidisciplinary intervention

D. J. Veldhuisen, A. Hoes, J. Cornel, 2004 .

Intracoronary Albunex: Its Effects on Left Ventricular Hemodynamics, Function, and Coronary Sinus Flow in Humans

P. Serruys, F. T. ten Cate, J. Cornel, 1993 .

The Role of Fluorine-18-Deoxyglucose Single Photon Emission Computed Tomography in Predicting Reversibility of Regional Wall Motion Abnormalities after Revascularization

Jeroen J. Bax, C. Visser, O. Kamp, 1995 .

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Giuseppe Ambrosio, Claes Held, Marco Valgimigli, 2012, The New England journal of medicine.

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.

J. Tijssen, J. Eikelboom, J. Cornel, 2021, Journal of the American College of Cardiology.

Colchicine for secondary prevention in coronary disease.

J. Cornel, S. Nidorf, A. Fiolet, 2020, European heart journal.

Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease.

R. Terkeltaub, J. Cornel, M. Pillinger, 2021, The American journal of medicine.

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy.

J. Cornel, E. Stroes, A. Mosterd, 2020, Circulation.

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy

A. van Rossum, J. Cornel, P. M. van de Ven, 2020, International journal of cardiology. Heart & vasculature.

Akinesis becoming dyskinesis during dobutamine stress echocardiography. A predictor of poor functional recovery after surgical revascularization.

J. Roelandt, J. Cornel, R. V. van Domburg, 1996, Chest.

Clinical experience with Albunex: a standard echocontrast agent for intravenous and intracoronary use.

P. Serruys, W. Vletter, J. Cornel, 1991, American journal of cardiac imaging.

Prediction of Improvement in Global and Regional Ventricular Function after Revascularization with FDG SPECT

Jeroen J. Bax, C. Visser, J. Cornel, 1997 .

Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans.

P. Serruys, F. T. ten Cate, J. Cornel, 1993, Circulation.

Article referred to: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.

J. Tijssen, J. Eikelboom, J. Cornel, 2021, European heart journal. Cardiovascular pharmacotherapy.

Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease.

J. Cornel, E. Boersma, D. Poldermans, 1994, The American journal of cardiology.

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.

L. Wallentin, R. Becker, J. Cornel, 2012, American heart journal.

E. Boersma, J. Cornel, I. Kardys, 2021, Diabetes & vascular disease research.

Coronary artery pseudoaneurysm: closure with pericardium-covered stents, guided by cardiac computed tomography angiography.

J. Cornel, F. M. van der Zant, R. Knol, 2013, The Canadian journal of cardiology.

Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation.

J. Roelandt, J. Cornel, R. V. van Domburg, 1995, The American journal of cardiology.

Relation between Viability, Improvement of Lvef and Heart Failure Symptoms after Revascularization

Jeroen J. Bax, C. Visser, J. Cornel, 1999 .

A man with diabetes and heart failure

J. Cornel, R. Nijveldt, E. Serné, 2004, The Lancet.

T wave normalization during dobutamine stress testing in patients with non-Q wave myocardial infarction. A marker of myocardial ischaemia?

A. Salustri, J. Roelandt, J. Cornel, 1996, European heart journal.

IMPACT OF SMOKING STATUS ON CLINICAL OUTCOMES WITH PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES MANAGED WITHOUT revascularization: INSIGHTS FROM THE TRILOGY ACS TRIAL

D. Prabhakaran, P. Armstrong, H. White, 2013 .

Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction.

A. Salustri, J. Roelandt, J. Cornel, 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Gerrit Metabolism Criteria − − Revascularization Using Different Perfusion Prediction of Improvement of Regional Left Ventricular Function After

Jeroen J. Bax, C. Visser, J. Cornel, 2006 .

Delayed recovery of hibernating myocardium after surgical revascularization: Implications for discrepancy between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability

Jeroen J. Bax, C. Visser, J. Cornel, 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Altered myocardial perfusion during dobutamine stress testing in silent versus symptomatic myocardial ischaemia assessed by quantitative MIBI SPET imaging

J. Roelandt, J. Cornel, A. Elhendy, 1996, European Journal of Nuclear Medicine.

Stress-induced left ventricular dysfunction in silent and symptomatic myocardial ischemia during dobutamine stress test.

J. Roelandt, J. Cornel, R. V. van Domburg, 1995, The American journal of cardiology.

Prognostic implications of a normal dobutamine-atropine stress echocardiogram in patients with chest pain.

J. Roelandt, J. Cornel, R. V. van Domburg, 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Preliminary clinical experience with intracoronary AlbunexR: a standardized echocontrast agent

P. Serruys, J. Cornel, P. Widimsky, 1993 .

European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction

S. Antoniou, J. Brachmann, J. Cornel, 2022, Advances in Therapy.

Safety of dobutamine-atropine stress myocardial perfusion scintigraphy.

Jeroen J. Bax, J. Roelandt, J. Cornel, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Safety of Dobutamine-AtropineStress Myocardial Perfusion Scintigraphy

Jeroen J. Bax, J. Roelandt, J. Cornel, 2006 .

Accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery stenosis in patients with myocardial infarction: the impact of extent and severity of left ventricular dysfunction.

J. Roelandt, J. Cornel, A. Elhendy, 1996, Heart.

Evaluation By Quantitative 99 m-Technetium MlBl SPECT and Echocardiography of Myocardial Perfusion and Wall Motion Abnormalities in Patients With Dobutamine-Induced ST-Segment Elevation

Marcel, Galal, J. Roelandt, 2004 .

Functional assessment of ALCAPA syndrome by dobutamine stress thallium-201 SPECT and echocardiography.

J. Roelandt, J. McGhie, A. Bogers, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Myocardial by Simultaneous Thallium-20 1 Single-Photon Emission Computed tomography

Marcel, Galal, J. Cornel, 2002 .

Relation Between Contractile Response of Akinetic Segments During Dobutamine Stress Echocardiogra lschemia Assesse B hy and Myocardial by Simultaneous Thallium-20 1 Single-Photon Emission Computed tomography

J. Cornel, A. Elhendy, P. Fioretti, 1996 .

The prognostic value of markers of inflammation in patients with troponin T-negative chest pain before discharge from the emergency department.

J. Tijssen, R. D. de Winter, O. Kamp, 2003, The American journal of medicine.

Coronary-artery bypass surgery with internal-thoracic-artery grafts.

J. Cornel, A. Arnold, M. Koorevaar, 1996, The New England journal of medicine.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Akinesis Becoming %I Echocardiography: A skinesis During HigkDose W&amine Stress arker of Myocardial lschemia or a Mechanical Phenomenon?

J. Roelandt, J. Cornel, P. Fioretti, 1994 .

Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization.

Jeroen J. Bax, C. Visser, J. Roelandt, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparison of thallium-201 rest-redistribution SPECT and FDG SPECT in predicting functional recovery after revascularization

Jeroen J. Bax, C. Visser, J. Cornel, 1996 .

Ticagrelor in Patients with Stable Coronary Disease and Diabetes.

Deepak L. Bhatt, Lawrence A Leiter, C. Held, 2019, The New England journal of medicine.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. Libby, P. Pais, P. Ridker, 2017, The New England journal of medicine.

The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.

T. Vree, J. Cornel, G. Wijnands, 1990, Chest.

Impaired glucose metabolism predicts mortality after a myocardial infarction.

J. Cornel, V. Umans, J. Bolk, 2001, International journal of cardiology.

Rosuvastatin in older patients with systolic heart failure.

A. Jánosi, J. McMurray, J. Cleland, 2007, The New England journal of medicine.

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

J. McMurray, J. Cleland, J. Cornel, 2009, Journal of the American College of Cardiology.

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

R. Collins, S. Cosgrove, P. Libby, 2017, The Lancet.

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

P. Libby, P. Ridker, R. Glynn, 2019, Circulation.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Deepak L. Bhatt, A. Parkhomenko, D. Prabhakaran, 2012, The New England journal of medicine.

Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein

J. Cornel, A. Mosterd, D. D. de Kleijn, 2020, PloS one.

Lenient versus strict rate control in patients with atrial fibrillation.

Otto Kamp, Hans L Hillege, Jan G P Tijssen, 2010, The New England journal of medicine.

Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.

D. Rizopoulos, Y. Pinto, J. Cornel, 2017, International journal of cardiology.

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)

Neha J. Pagidipati, R. Holman, P. Armstrong, 2017, Circulation.

Abstract 086: Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes: International Insights From the TECOS Trial

Neha J. Pagidipati, R. Holman, P. Armstrong, 2017 .

Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT‐proBNP, troponin T, and CRP in the Bio‐SHiFT study

D. Rizopoulos, E. Boersma, J. Cornel, 2018, American heart journal.

In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessment

J. Cornel, I. Kardys, K. M. Akkerhuis, 2017, Netherlands Heart Journal.

Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer–Alkmaar heart failure study

A. Hoes, N. Zuithoff, J. Cornel, 2006, Heart.

A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial.

J. Kasprzak, R. Becker, R. Mehran, 2011, American heart journal.

Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography.

F J Ten Cate, A Salustri, D Keane, 1995, Circulation.

Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy.

E. Boersma, J. Cornel, V. Umans, 2010, American heart journal.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Diane M. Miller, Natalia E. Shilkina, M. C. Cantero, 2018, Lancet.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

High-pitch prospective ECG-triggered helical coronary computed tomography angiography in clinical practice: image quality and radiation dose

J. Cornel, A. Rossum, P. Knaapen, 2014, The International Journal of Cardiovascular Imaging.

Predictors of fatal and non‐fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A‐1, high‐sensitivity C‐reactive peptide and N‐terminal pro B‐type natriuretic peptide

John G F Cleland, John Wikstrand, Timo Kuusi, 2009, European journal of heart failure.

Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease

Y. Pinto, J. Tijssen, P. D. de Leeuw, 2020, American Heart Journal.

Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram.

J R Roelandt, J D Kasprzak, M L Simoons, 2000, European heart journal.

Low-dose dobutamine echocardiography and rest-redistribution thallium-201 tomography in the assessment of spontaneous recovery of left ventricular function after recent myocardial infarction.

A. Salustri, J. Roelandt, J. Cornel, 1996, American heart journal.

Assessment of Myocardial Viability by Pharmacological Stress Echocardiography

J. Cornel, P. Fioretti, 1995 .

GRACE and TIMI risk scores but not stress imaging predict long-term cardiovascular follow-up in patients with chest pain after a rule-out protocol

R. D. de Winter, O. Kamp, J. Cornel, 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

E. Ohman, D. Ardissino, H. Bueno, 2017, The Lancet.

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.

W. Koenig, C. Ballantyne, J. Kastelein, 2016, JAMA.

The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.

J. Cornel, P. M. van de Ven, T. Germans, 2018, JACC. Cardiovascular imaging.

Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography.

J J Bax, Jeroen J. Bax, C. Visser, 1996, Journal of the American College of Cardiology.

Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease.

J R Roelandt, J. Roelandt, J. Cornel, 1994, The American journal of medicine.

Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data.

Jeroen J. Bax, J. Cornel, W. Wijns, 1997, Journal of the American College of Cardiology.

Time Course of Functional Recovery of Stunned and Hibernating Segments After Surgical Revascularization

J J Bax, Jeroen J. Bax, C. Visser, 2001, Circulation.

Dobutamine thallium-201 SPECT imaging for assessment of peri-infarction and remote myocardial ischemia.

J. Roelandt, J. Cornel, R. V. van Domburg, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both?

A. Salustri, J. Roelandt, J. Cornel, 1997, Circulation.

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.

C. Held, K. Mahaffey, A. Budaj, 2011, European heart journal.

Coronary artery disease in patients with atypical chest pain with and without diabetes mellitus assessed with coronary CT angiography

J. Cornel, F. M. van der Zant, P. Knaapen, 2014, BMJ Open Diabetes Research and Care.

Possible Bradycardic Mode of Death and Successful Pacemaker Treatment in a Large Family with Features of Long QT Syndrome Type 3 and Brugada Syndrome

A. Wilde, H. Crijns, J. Cornel, 2001, Journal of cardiovascular electrophysiology.

Trends in incidence of infective endocarditis at the Medical Center of Alkmaar

J. Cornel, A. Vonk, Marije M. G. Krul, 2015, Netherlands Heart Journal.

Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS

R. Holman, H. Rodbard, G. Bakris, 2016, Diabetes Care.

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.

P. Libby, P. Ridker, R. Glynn, 2018, Journal of the American College of Cardiology.

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.

M. Pencina, R. Holman, P. Armstrong, 2016, JAMA cardiology.

Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial.

A. Budaj, A. Siegbahn, L. Wallentin, 2022, Journal of the American Heart Association.

Endothelial dysfunction and reduced myocardial perfusion reserve in heart failure secondary to coronary artery disease.

W. Vaalburg, J. Cornel, H. Siebelink, 2003, The American journal of cardiology.

Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography.

Jeroen J. Bax, C. Visser, O. Kamp, 1997, Journal of the American College of Cardiology.

Rate control efficacy in permanent atrial fibrillation

D. J. Veldhuisen, J. Tijssen, H. Crijns, 2019 .

RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.

I. V. Van Gelder, M. Rienstra, J. Tijssen, 2006, American heart journal.

FDG SPECT to Assess Myocardial Viability

Jeroen J. Bax, C. Visser, J. Cornel, 1998 .

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale.

C. Held, B. Lewis, R. Diaz, 2009, American heart journal.

Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.

J. Eikelboom, J. Cornel, C. Budgeon, 2022, International journal of cardiology.

Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy.

J. Cornel, A. Mosterd, D. D. de Kleijn, 2021, Atherosclerosis.

The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial

J. Eikelboom, J. Cornel, C. Budgeon, 2022, Clinical Drug Investigation.

Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.

A. Keech, J. Tijssen, J. Eikelboom, 2021, European heart journal.

Detection of left coronary artery stenosis by transoesophageal echocardiography.

J. Roelandt, M. Taams, J. Cornel, 1988, European heart journal.

Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting

Jeroen J. Bax, J. Roelandt, J. Kasprzak, 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial.

C. Held, P. Armstrong, F. Van de Werf, 2014, American heart journal.

Quantitative assessment of myocardial blood flow by contrast two-dimensional echocardiography: initial clinical observations.

P. Serruys, J. Roelandt, F. T. ten Cate, 1987, American journal of physiologic imaging.

Impact of severity of coronary artery stenosis and the collateral circulation on the functional outcome of dyssynergic myocardium after revascularization in patients with healed myocardial infarction and chronic left ventricular dysfunction.

Jeroen J. Bax, J. Roelandt, J. Cornel, 1997, The American journal of cardiology.

Echocardiographic studies of dobutamine-induced ST-segment elevation before and after coronary artery bypass grafting in patients with old Q-wave myocardial infarction.

Jeroen J. Bax, J. Roelandt, J. Kasprzak, 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T.

J. Tijssen, R. D. de Winter, J. Cornel, 2009, Clinical chemistry.

A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.

J. Kasprzak, R. Becker, R. Mehran, 2013, European heart journal.

Reply to Huang

E. Boersma, J. Cornel, V. Umans, 2011 .

Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements

J. Eikelboom, J. Cornel, C. V. D. van den Ende, 2023, Annals of Internal Medicine.

Comprehensive analysis of aortic valve vegetation with anyplane, paraplane, and three-dimensional echocardiography.

A. Salustri, J. Roelandt, J. Kasprzak, 1996, European heart journal.

Safety and efficacy of a nurse-led clinic for post-operative coronary artery bypass grafting patients.

J. Cornel, V. Umans, C. Burgersdijk, 2006, International journal of cardiology.

Diagnostic and Therapeutic Usefulness of Coronary Computed Tomography Angiography in Out-Clinic Patients Referred for Chest Pain.

J. Cornel, F. M. van der Zant, R. Knol, 2015, The American journal of cardiology.

Detection of myocardial viability with F-18-fluorodeoxyglucose and single photon emission computed tomography.

Jeroen J. Bax, C. Visser, J. Roelandt, 1997, Giornale italiano di cardiologia.

Septal Midwall Late Gadolinium Enhancement in Ischemic Cardiomyopathy and Nonischemic Dilated Cardiomyopathy-Characteristics and Prognosis.

J. Cornel, P. M. van de Ven, T. Germans, 2023, American Journal of Cardiology.

Ruling out coronary artery disease in women with atypical chest pain: results of calcium score combined with coronary computed tomography angiography and associated radiation exposure.

J. Cornel, V. Umans, F. M. van der Zant, 2015, Journal of women's health.

Improved identification of coronary artery disease in patients with left bundle branch block by use of dobutamine stress echocardiography and comparison with myocardial perfusion tomography.

G. Mairesse, T. Marwick, J. Cornel, 1995, The American journal of cardiology.

Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial.

J. Eikelboom, J. Cornel, A. Mosterd, 2023, Clinical drug investigation.

Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography.

J. Roelandt, J. Cornel, R. V. van Domburg, 1996, The American journal of cardiology.

Effect of coronary artery bypass surgery on myocardial perfusion and ejection fraction response to inotropic stimulation in patients without improvement in resting ejection fraction.

Jeroen J. Bax, J. Roelandt, J. Cornel, 2000, The American journal of cardiology.

Regional Perfusion and Metabolism before Revascularization Compared with Functional Outcome

Jeroen J. Bax, C. Visser, J. Cornel, 1997 .

Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.

Jeroen J. Bax, C. Visser, R. Heine, 1997, Nuclear medicine communications.

Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio

P. Libby, P. Ridker, J. Cornel, 2022, JAMA cardiology.

Electronic health record-based facilitation of familial hypercholesterolaemia detection sensitivity of different algorithms in genetically confirmed patients

J. Cornel, R. Akyea, N. Qureshi, 2022, European heart journal. Digital health.

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government

M. Spedding, J. Cornel, G. Rongen, 2023, Applied Health Economics and Health Policy.

Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial

M. Keltai, A. Budaj, L. Wallentin, 2010 .

C. Held, C. Cannon, K. Mahaffey, 2014, Circulation.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Deepak L. Bhatt, A. Parkhomenko, D. Prabhakaran, 2012, The New England journal of medicine.

Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization A Substudy From the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial